What criteria will UHC use to determine if a drug has no clinical advantage over other drugs in the same therapeutic category?
Drugs considered to have no clinical advantage that may be excluded from the Empire Plan Flexible Formulary Drug List (and, therefore, not covered) include any products that: Contain an active ingredient available in and therapeutically equivalent to another drug covered in that therapeutic category; Contain an active ingredient which is a modified version of and therapeutically equivalent to another covered prescription drug; or Are available in over-the-counter form or comprised of components that are available in over-the-counter form or equivalent.
Related Questions
- Where can I find a current list of drugs on the Medicaid Preferred Drug List (PDL) and the clinical criteria for approving use of the drugs?
- What criteria will UHC use to determine if a drug has no clinical advantage over other drugs in the same therapeutic category?
- Are there specific criteria used to determine whether patients can receive an investigational drug outside a clinical trial?
